🇺🇸 Fluoroquinolone in United States
25 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 25
Most-reported reactions
- Cardiac Arrest — 4 reports (16%)
- Pain In Extremity — 3 reports (12%)
- Tendon Rupture — 3 reports (12%)
- Toxicity To Various Agents — 3 reports (12%)
- Acute Respiratory Distress Syndrome — 2 reports (8%)
- Anxiety — 2 reports (8%)
- Arthralgia — 2 reports (8%)
- Ascites — 2 reports (8%)
- Asthenia — 2 reports (8%)
- Blood Bilirubin Increased — 2 reports (8%)
Other Other approved in United States
Frequently asked questions
Is Fluoroquinolone approved in United States?
Fluoroquinolone does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Fluoroquinolone in United States?
Haiphong University of Medicine and Pharmacy is the originator. The local marketing authorisation holder may differ — check the official source linked above.